Trials / Withdrawn
WithdrawnNCT01101347
A Feasibility Study of the Surpass Aneurysm-Embolization System in Intracranial Arteries
- Status
- Withdrawn
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 10 (estimated)
- Sponsor
- Surpass Medical Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate safety and performance of the Surpass Aneurysm-Embolization System.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Aneurysm-Embolization System |
Timeline
- First posted
- 2010-04-09
- Last updated
- 2010-11-30
Source: ClinicalTrials.gov record NCT01101347. Inclusion in this directory is not an endorsement.